SCHEMBL9528762

SCHEMBL9528762

CC=CCc1nc(C(C)CC)nn1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.37

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AGTR2 P50052 12/20 0.37
AGTR1 P30556 11/20 0.37
GP6 Q9HCN6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9528757 1.00 AGTR2 (0.37) AGTR2AGTR1GP6
SCHEMBL9529011 0.92 AGTR1 (0.37) AGTR2AGTR1
SCHEMBL9529015 0.92 AGTR1 (0.37) AGTR2AGTR1
SCHEMBL9529105 0.89 AGTR1 (0.40) AGTR2AGTR1
SCHEMBL9531030 0.87 AGTR1 (0.42) AGTR2AGTR1
SCHEMBL9532681 0.87 AGTR2 (0.45) AGTR2AGTR1
SCHEMBL6005597 0.86 AGTR1 (0.37) AGTR2AGTR1
SCHEMBL9553640 0.86 AGTR1 (0.36) AGTR2AGTR1
SCHEMBL9553637 0.86 AGTR1 (0.36) AGTR2AGTR1
SCHEMBL6005759 0.86 AGTR1 (0.37) AGTR2AGTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed